Treatment with incomplete Freund's adjuvant and Listeria monocytogenes delays diabetes via an interleukin‑17‑secretion‑independent pathway

Wang,Hai‑Ping; He,Zhi‑Gao

doi:10.3892/etm.2015.2328

Treatment with incomplete Freund's adjuvant and Listeria monocytogenes delays diabetes via an interleukin‑17‑secretion‑independent pathway

Authors:
- Hai‑Ping Wang
- Zhi‑Gao He
View Affiliations

Affiliations: Department of Pharmacy, East Hospital of Tongji University, Shanghai 200120, P.R. China
Published online on: March 3, 2015 https://doi.org/10.3892/etm.2015.2328
Pages: 1934-1938

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Non‑obese diabetes (NOD) mice are widely used as an animal model in studies of type I diabetes (TID). Treatment with complete Freund's adjuvant (CFA) in pro‑diabetic NOD mice is known to inhibit disease progression by activating CD1d‑specific natural killer (NK) T cells and inducing interleukin (IL)‑17 secretion in innate immune cells. The aim of the present study was to examine the effect of incomplete Freund's adjuvant (IFA) and L. monocytogenes treatment on the development of TID in NOD mice. This combined treatment of IFA and L. monocytogenes, a microbe that infects the liver and is primarily combatted by NK and cytotoxic T lymphocytes, was applied to mimic CFA treatment in pro‑diabetic NOD mice. The combined IFA + L. monocytogenes treatment effectively delayed TID development in the NOD mice. In contrast to CFA, the IFA + L. monocytogenes treatment did not induce T cells or innate immune cells to secrete IL‑17. However, increased levels of regulatory T cells were detected. Furthermore, IFA + L. monocytogenes mice exhibited higher levels of IgG2a, although no notable T helper 1 cell response was observed when compared with the CFA or IFA control treated mice. Therefore, combined IFA + L. monocytogenes treatment was shown to delay TID development in NOD mice via a novel mechanism, which was independent from the secretion of IL‑17 by CFA‑activated NKT cells.

View Figures

View References

1	Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K and Tochino Y: Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu. 29:1–13. 1980.PubMed/NCBI
2	Aoki CA, Borchers AT, Ridgway WM, Keen CL, Ansari AA and Gershwin ME: NOD mice and autoimmunity. Autoimmun Rev. 4:373–379. 2005. View Article : Google Scholar : PubMed/NCBI
3	Lehuen A, Diana J, Zaccone P and Cooke A: Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol. 10:501–513. 2010. View Article : Google Scholar : PubMed/NCBI
4	Novak J, Griseri T, Beaudoin L and Lehuen A: Regulation of type 1 diabetes by NKT cells. Int Rev Immunol. 26:49–72. 2007. View Article : Google Scholar : PubMed/NCBI
5	Godfrey DI and Kronenberg M: Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest. 114:1379–1388. 2004. View Article : Google Scholar : PubMed/NCBI
6	Sadelain MW, Qin HY, Lauzon J and Singh B: Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes. 39:583–589. 1990. View Article : Google Scholar : PubMed/NCBI
7	Mori Y, Kodaka T, Kato T, Kanagawa EM and Kannagawa O: Critical role of IFN-gamma in CFA-mediated protection of NOD mice from diabetes development. Int Immunol. 21:1291–1299. 2009. View Article : Google Scholar : PubMed/NCBI
8	Kukeja A, Costi G, Marker J, Zhang CH, Sinha S and Maclaren N: NKT cell defects in NOD mice suggest therapeutic opportunities. J Autoimmun. 19:117–28. 2002. View Article : Google Scholar : PubMed/NCBI
9	Ryu S, Kodama S, Ryu K, Schoenfeld DA and Faustman DL: Reversal of established autoimmune diabetes by restoration of endogenous beta cell function. J Clin Invest. 108:63–72. 2001. View Article : Google Scholar : PubMed/NCBI
10	McInerney MF, Pek SB and Thomas DW: Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice. Diabetes. 40:715–725. 1991. View Article : Google Scholar : PubMed/NCBI
11	Lee IF, Qin H, Trudeau J, Dutz J and Tan R: Regulation of autoimmune diabetes by complete Freund's adjuvant is mediated by NK cells. J Immunol. 172:937–942. 2004. View Article : Google Scholar : PubMed/NCBI
12	Lee IF, van den Elzen P, Tan R and Priatel JJ: NKT cells are required for complete Freund's adjuvant-mediated protection from autoimmunediabetes. J Immunol. 187:2898–2904. 2011. View Article : Google Scholar : PubMed/NCBI
13	Qin HY, Elliott JF, Lakey JR, Rajotte RV and Singh B: Endogenous immune response to glutamic acid decarboxylase (gad67) in NOD mice is modulated by adjuvant immunotherapy. J Autoimmun. 11:591–601. 1998. View Article : Google Scholar : PubMed/NCBI
14	Qin HY, Chaturvedi P and Singh B: In vivo apoptosis of diabetogenic T cells in nod mice by IFN-gamma/TNF-alpha. Int Immunol. 16:1723–1732. 2004. View Article : Google Scholar : PubMed/NCBI
15	Qin HY and Singh B: Bcg vaccination prevents insulin-dependent diabetes mellitus (iddm) in NOD mice after disease acceleration with cyclophosphamide. J Autoimmun. 10:271–278. 1997. View Article : Google Scholar : PubMed/NCBI
16	Qin HY, Sadelain MW, Hitchon C, Lauzon J and Singh B: Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J Immunol. 150:2072–2080. 1993.PubMed/NCBI
17	Tisch R, Wang B and Serreze DV: Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent. J Immunol. 163:1178–1187. 1999.PubMed/NCBI
18	Alam C, Valkonen S, Palagani V, Jalava J, Eerola E and Hӓnninen A: Inflammatory tendencies and overproduction of il-17 in the colon of young NOD mice are counteracted with diet change. Diabetes. 59:2237–2246. 2010. View Article : Google Scholar : PubMed/NCBI
19	Tigno-Aranjuez JT, Lehmann PV and Tary-Lehmann M: Dissociated induction of cytotoxicity and dth by cfa and cpg. J Immunother. 32:389–398. 2009. View Article : Google Scholar : PubMed/NCBI
20	Lockhart E, Green AM and Flynn JL: Il-17 production is dominated by gammadelta t cells rather than cd4 t cells during mycobacterium tuberculosis infection. J Immunol. 177:4662–4669. 2006. View Article : Google Scholar : PubMed/NCBI
21	Duarte N, Stenström M, Campino S, et al: Prevention of diabetes in nonobese diabetic mice mediated by cd1d-restricted nonclassical nkt cells. J Immunol. 173:3112–3118. 2004. View Article : Google Scholar : PubMed/NCBI
22	Lee IF, Qin H, Priatel JJ and Tan R: Critical role for ifn-gamma in natural killer cell-mediated protection from diabetes. Eur J Immunol. 38:82–89. 2008. View Article : Google Scholar : PubMed/NCBI
23	Subramanian L, Blumenfeld H, Tohn R, et al: Nkt cells stimulated by long fatty acyl chain sulfatides significantly reduce the incidence of type 1 diabetes in nonobese diabetic mice [corrected]. PLoS One. 7:e377712012. View Article : Google Scholar : PubMed/NCBI
24	Shimamura M, Huang YY, Goji H, Endo S, Migishima R and Yokoyama M: Regulation of immunological disorders by invariant vα19-j α33 tcr-bearing cells. Immunobiology. 216:374–378. 2011. View Article : Google Scholar : PubMed/NCBI
25	Emoto M, Yoshida T, Fukuda T, et al: Alpha-galactosylceramide promotes killing of Listeria monocytogenes within the macrophage phagosome through invariant nkt-cell activation. Infect Immun. 78:2667–2676. 2010. View Article : Google Scholar : PubMed/NCBI
26	Yeung VP, Gieni RS, Umetsu DT and DeKruyff RH: Heat-killed listeria monocytogenes as an adjuvant converts established murine Th2-dominated immune responses into th1-dominated responses. J Immunol. 161:4146–4152. 1998.PubMed/NCBI
27	Kukeja A, Costi G, Marker J, Zhang CH, Sinha S and Maclaren N: NKT cell defects in NOD mice suggest therapeutic opportunities. J Autoimmun. 19:117–28. 2002. View Article : Google Scholar : PubMed/NCBI
28	Tellier J, Andrianjaka A, Vicente R, et al: Increased thymic development of regulatory T cells in nod mice is functionally dissociated from type I diabetes susceptibility. Eur J Immunol. 43:1356–1362. 2013. View Article : Google Scholar : PubMed/NCBI